Literature DB >> 21795548

Cell-type-specific CCK2 receptor signaling underlies the cholecystokinin-mediated selective excitation of hippocampal parvalbumin-positive fast-spiking basket cells.

Soo Yeun Lee1, Csaba Földy, János Szabadics, Ivan Soltesz.   

Abstract

Parvalbumin-positive (PV+) fast-spiking basket cells are thought to play key roles in network functions related to precise time keeping during behaviorally relevant hippocampal synchronous oscillations. Although they express relatively few receptors for neuromodulators, the highly abundant and functionally important neuropeptide cholecystokinin (CCK) is able to selectively depolarize PV+ basket cells, making these cells sensitive biosensors for CCK. However, the molecular mechanisms underlying the CCK-induced selective and powerful excitation of PV+ basket cells are not understood. We used single and paired patch-clamp recordings in acute rat hippocampal slices, in combination with post hoc identification of the recorded interneurons, to demonstrate that CCK acts via G-protein-coupled CCK2 receptors to engage sharply divergent intracellular pathways to exert its cell-type-selective effects. In contrast to CCK2 receptors on pyramidal cells that signal through the canonical G(q)-PLC pathway to trigger endocannabinoid-mediated signaling events, CCK2 receptors on neighboring PV+ basket cells couple to an unusual, pertussis-toxin-sensitive pathway. The latter pathway involves ryanodine receptors on intracellular calcium stores that ultimately activate a nonselective cationic conductance to depolarize PV+ basket cells. CCK has highly cell-type-selective effects even within the PV+ cell population, as the PV+ dendrite-targeting bistratified cells do not respond to CCK. Together, these results demonstrate that an abundant ligand such as CCK can signal through the same receptor in different neurons to use cell-type-selective signaling pathways to provide divergence and specificity to its effects.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21795548      PMCID: PMC3158608          DOI: 10.1523/JNEUROSCI.1970-11.2011

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  75 in total

Review 1.  Biochemical and pharmacological control of the multiplicity of coupling at G-protein-coupled receptors.

Authors:  Emmanuel Hermans
Journal:  Pharmacol Ther       Date:  2003-07       Impact factor: 12.310

Review 2.  Endocannabinoid-mediated control of synaptic transmission.

Authors:  Masanobu Kano; Takako Ohno-Shosaku; Yuki Hashimotodani; Motokazu Uchigashima; Masahiko Watanabe
Journal:  Physiol Rev       Date:  2009-01       Impact factor: 37.312

3.  Requirement for CB1 but not GABAB receptors in the cholecystokinin mediated inhibition of GABA release from cholecystokinin expressing basket cells.

Authors:  Sang-Hun Lee; Ivan Soltesz
Journal:  J Physiol       Date:  2010-12-20       Impact factor: 5.182

4.  Granule cells in the CA3 area.

Authors:  János Szabadics; Csaba Varga; János Brunner; Kang Chen; Ivan Soltesz
Journal:  J Neurosci       Date:  2010-06-16       Impact factor: 6.167

5.  Brain-state- and cell-type-specific firing of hippocampal interneurons in vivo.

Authors:  Thomas Klausberger; Peter J Magill; László F Márton; J David B Roberts; Philip M Cobden; György Buzsáki; Peter Somogyi
Journal:  Nature       Date:  2003-02-20       Impact factor: 49.962

6.  An agonist-induced switch in G protein coupling of the gonadotropin-releasing hormone receptor regulates pulsatile neuropeptide secretion.

Authors:  Lazar Z Krsmanovic; Nadia Mores; Carlos E Navarro; Krishan K Arora; Kevin J Catt
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-18       Impact factor: 11.205

7.  Cholecystokinins in rat cerebral cortex: identification, purification and characterization by immunochemical methods.

Authors:  G J Dockray
Journal:  Brain Res       Date:  1980-04-21       Impact factor: 3.252

8.  Pharmacological profile of (R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo- 5-phenyl-1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea (YM022), a new potent and selective gastrin/cholecystokinin-B receptor antagonist, in vitro and in vivo.

Authors:  A Nishida; K Miyata; R Tsutsumi; H Yuki; S Akuzawa; A Kobayashi; T Kamato; H Ito; M Yamano; Y Katuyama
Journal:  J Pharmacol Exp Ther       Date:  1994-05       Impact factor: 4.030

9.  The trp gene is essential for a light-activated Ca2+ channel in Drosophila photoreceptors.

Authors:  R C Hardie; B Minke
Journal:  Neuron       Date:  1992-04       Impact factor: 17.173

10.  CCK and gastrin inhibit adenylate cyclase activity through a pertussis toxin-sensitive mechanism in the tumoral rat pancreatic acinar cell line AR 4-2J.

Authors:  J L Scemama; P Robberecht; M Waelbroeck; P De Neef; L Pradayrol; N Vaysse; J Christophe
Journal:  FEBS Lett       Date:  1988-12-19       Impact factor: 4.124

View more
  29 in total

1.  Comprehensive Estimates of Potential Synaptic Connections in Local Circuits of the Rodent Hippocampal Formation by Axonal-Dendritic Overlap.

Authors:  Carolina Tecuatl; Diek W Wheeler; Nate Sutton; Giorgio A Ascoli
Journal:  J Neurosci       Date:  2020-12-23       Impact factor: 6.167

2.  Molecular interrogation of hypothalamic organization reveals distinct dopamine neuronal subtypes.

Authors:  Roman A Romanov; Amit Zeisel; Joanne Bakker; Fatima Girach; Arash Hellysaz; Raju Tomer; Alán Alpár; Jan Mulder; Frédéric Clotman; Erik Keimpema; Brian Hsueh; Ailey K Crow; Henrik Martens; Christian Schwindling; Daniela Calvigioni; Jaideep S Bains; Zoltán Máté; Gábor Szabó; Yuchio Yanagawa; Ming-Dong Zhang; Andre Rendeiro; Matthias Farlik; Mathias Uhlén; Peer Wulff; Christoph Bock; Christian Broberger; Karl Deisseroth; Tomas Hökfelt; Sten Linnarsson; Tamas L Horvath; Tibor Harkany
Journal:  Nat Neurosci       Date:  2016-12-19       Impact factor: 24.884

3.  First and second generation antipsychotics influence hippocampal gamma oscillations by interactions with 5-HT3 and D3 receptors.

Authors:  Steffen B Schulz; Karin E Heidmann; Arpad Mike; Zin-Juan Klaft; Uwe Heinemann; Zoltan Gerevich
Journal:  Br J Pharmacol       Date:  2012-12       Impact factor: 8.739

4.  Cholecystokinin-Expressing Interneurons of the Medial Prefrontal Cortex Mediate Working Memory Retrieval.

Authors:  Robin Nguyen; Sridevi Venkatesan; Mary Binko; Jee Yoon Bang; Janine D Cajanding; Chloe Briggs; Derya Sargin; Itaru Imayoshi; Evelyn K Lambe; Jun Chul Kim
Journal:  J Neurosci       Date:  2020-01-31       Impact factor: 6.167

Review 5.  Sticking out of the crowd: the molecular identity and development of cholecystokinin-containing basket cells.

Authors:  Erik Keimpema; Alex Straiker; Ken Mackie; Tibor Harkany; Jens Hjerling-Leffler
Journal:  J Physiol       Date:  2012-01-04       Impact factor: 5.182

6.  Neuropeptides Modulate Local Astrocytes to Regulate Adult Hippocampal Neural Stem Cells.

Authors:  Brent Asrican; Josh Wooten; Ya-Dong Li; Luis Quintanilla; Feiran Zhang; Connor Wander; Hechen Bao; Chia-Yu Yeh; Yan-Jia Luo; Reid Olsen; Szu-Aun Lim; Jessica Hu; Peng Jin; Juan Song
Journal:  Neuron       Date:  2020-09-01       Impact factor: 17.173

Review 7.  New dimensions of interneuronal specialization unmasked by principal cell heterogeneity.

Authors:  Esther Krook-Magnuson; Csaba Varga; Sang-Hun Lee; Ivan Soltesz
Journal:  Trends Neurosci       Date:  2011-11-24       Impact factor: 13.837

8.  The Brain Prize 2011: From Microcircuit Organization to Constellations of Brain Rhythms.

Authors:  Ivan Soltesz
Journal:  Trends Neurosci       Date:  2011-09-13       Impact factor: 13.837

9.  Increased cholecystokinin labeling in the hippocampus of a mouse model of epilepsy maps to spines and glutamatergic terminals.

Authors:  M S Wyeth; N Zhang; C R Houser
Journal:  Neuroscience       Date:  2011-12-03       Impact factor: 3.590

10.  Interaction between the cholecystokinin and endogenous cannabinoid systems in cued fear expression and extinction retention.

Authors:  Mallory E Bowers; Kerry J Ressler
Journal:  Neuropsychopharmacology       Date:  2014-09-01       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.